ribavirin has been researched along with Hepatitis B Virus Infection in 111 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (8.11) | 18.7374 |
| 1990's | 8 (7.21) | 18.2507 |
| 2000's | 53 (47.75) | 29.6817 |
| 2010's | 37 (33.33) | 24.3611 |
| 2020's | 4 (3.60) | 2.80 |
| Authors | Studies |
|---|---|
| Hosmane, RS; Korba, BE; Zhang, N; Zhang, P | 1 |
| Campos, RH; Cavallaro, LV; Gagey, D; Lantaño, B; Moglioni, AG; Moltrasio, GY; Ugliarolo, EA | 1 |
| Agrawal, B; Kumar, R; Liang, C; Shakya, N; Tyrrell, DL; Vedi, S | 1 |
| Abd El-Wahab, EW; Helmy, SH; Nagaty, A | 1 |
| Masuda, T; Miyasaka, A; Okamoto, H; Suzuki, A; Takikawa, Y; Yoshida, Y | 1 |
| Amano, N; Genda, T; Ikeda, Y; Kabemura, D; Kita, Y; Murata, A; Sato, S; Shimada, Y; Tsuzura, H; Yatagai, N | 1 |
| Akhavan, S; Calin, R; Demeret, S; Jaspard, M; Katlama, C; Mallet, V; Peytavin, G; Pourcher, V; Poynard, T; Roque-Afonso, AM; Thibault, V; Todesco, E | 1 |
| Angiola, A; Caruso, A; Casari, S; Castelli, F; Festa, E; Gargiulo, F; Lanza, P; Nasta, P; Odolini, S; Rodella, A; Urbinati, L; Vavassori, A; Viganò, M; Zaltron, S | 1 |
| Furusyo, N; Hayashi, T; Murata, M; Ogawa, E; Toyoda, K; Ura, K | 1 |
| Chen, PJ; Chuang, WL; Dai, CY; Hsieh, MH; Huang, CF; Huang, CI; Huang, JF; Kao, JH; Liu, CJ; Liu, TW; Su, TH; Wang, SC; Yeh, ML; Yu, ML | 1 |
| Abou-Samra, AB; Butt, AA; Shaikh, OS; Yan, P | 1 |
| Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kee, KM; Kuo, FY; Lu, SN; Wang, JH; Yen, YH | 1 |
| Wahid, B | 1 |
| Hu, KQ; Zhang, YY | 1 |
| Chen, X; Guo, X; Ruan, P; Yang, G; Yuan, J; Zhang, M; Zhou, B | 1 |
| Liu, CJ | 1 |
| Hoshino, T; Kakizaki, S; Koitabashi, E; Kudo, T; Naganuma, A; Okamoto, H; Ryusaki, K; Sakamoto, N; Takagi, H; Uehara, S | 1 |
| Coppola, N; Filippini, P; Martini, S; Pisaturo, M; Sagnelli, C; Sagnelli, E | 1 |
| Chen, DS; Chen, PJ; Kao, JH; Liu, CJ; Tseng, TC | 1 |
| Pol, S; Vallet-Pichard, A | 1 |
| Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Yeh, ML; Yu, ML | 1 |
| Guillevin, L; Pagnoux, C | 1 |
| Pár, A; Pár, G | 1 |
| Gault, E; Girard, PM; Gozlan, J; Lacombe, K; Raguin, G | 1 |
| Chao, YC; Chen, CL; Chen, DS; Chen, PJ; Chuang, WL; Jeng, YM; Kao, JH; Kuo, HT; Lee, CM; Liao, LY; Lin, CL; Liu, CH; Liu, CJ; Lu, SN; Su, WW; Tung, SY; Wu, SS; Yang, SS; Yu, ML | 1 |
| Gordon, SC; Sherman, KE | 1 |
| Alberti, A | 2 |
| Schildgen, O | 1 |
| Gao, J; Kang, P; Li, SC; Sun, LJ; Yu, JW; Zhao, YH | 1 |
| Aghemo, A; Agnelli, F; Colombo, M; Donato, MF; Iavarone, M; Lampertico, P; Rumi, MG; Viganò, M | 1 |
| Chang, JJ; Chen, LW; Chien, RN; Lin, CL; Liu, CJ; Yen, CL | 1 |
| Roberts, EA; Yeung, LT | 1 |
| Berg, T; Potthoff, A; Wedemeyer, H | 1 |
| Mallat, ME; Sharara, AI | 1 |
| Abe, H; Araoka, T; Doi, T; Fukatsu, A; Iehara, N; Kishi, F; Kishi, S; Kita, T; Kondo, N; Matsubara, T; Matsuura, M; Mima, A; Murakami, T; Nagai, K; Shigeta, R; Takahashi, T; Yamamoto, S; Yoshikawa, K | 1 |
| Chu, CJ; Lee, SD | 1 |
| Jmelnitzky, AC; Jorge, O; Manero, E | 1 |
| Cheveau, A; Larrat, S; Leroy, V; Levast, M; Morand, P; Nicod, S; Plages, A; Seigneurin, JM; Thelu, MA; Zarski, JP | 1 |
| Calabrese, L; Ferri, C; Govoni, M | 1 |
| Behrens, R; Enninger, A; Gerner, P; Hilbich, J; Kliemann, G; Walther, F; Wenzl, TG; Wirth, S | 1 |
| Ciancio, A; Rizzetto, M | 1 |
| Bahgat, MM; El-Gammal, NE; Emara, MH; Mohamed, LA | 1 |
| Christodoulou, DK; Katsanos, KH; Tsianos, EV; Tsianos, VE; Vagias, I; Zervou, E; Zioga, H; Zois, CD | 1 |
| Chen, DS; Chen, PJ; Chuang, WL; Dai, CY; Hu, TH; Huang, JF; Hung, CH; Kao, JH; Lee, CM; Lin, ZY; Liu, CJ; Lu, SN; Wang, JH; Yeh, ML; Yu, ML | 1 |
| Chen, CH; Hu, TH; Huang, CM; Hung, CH; Lee, CM; Lu, SN; Wang, JH | 1 |
| Chen, CH; Hu, TH; Huang, CM; Hung, CH; Lee, CM; Lu, SN; Tsai, MC; Wang, JH | 1 |
| Kudo, M | 1 |
| Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E | 1 |
| Hu, HD; Hu, P; Liu, JY; Ren, H; Sheng, YJ; Tong, SW; Wang, J; Zhang, DZ; Zhong, Q; Zhou, Z | 1 |
| Alves, AL; Augusto, F; Cardoso, C; Freire, R; Gonçalves, M; Oliveira, AP; Quintana, C | 1 |
| Biliotti, E; Gallinaro, V; Giusto, M; Grieco, S; Merli, M; Spaziante, M; Taliani, G; Zacharia, S | 1 |
| Choi, Y; Li, K; Rahal, H; Saab, S; Tong, M | 1 |
| Chao, YC; Chen, CL; Chen, DS; Chen, PJ; Chuang, WL; Kao, JH; Kuo, HT; Lee, CM; Liao, LY; Lin, CL; Liu, CH; Liu, CJ; Lu, SN; Su, WW; Tung, SY; Wu, SS; Yang, HC; Yang, SS; Yu, ML | 1 |
| Adams, P | 1 |
| Chen, DS; Chen, PJ; Jeng, YM; Kao, JH; Lai, MY; Liu, CJ | 1 |
| Färkkilä, M | 1 |
| Maier, KP | 1 |
| Bevilacqua, P; Bozzola, L; Brown, D; de Lalla, F; Dusheiko, G; Fabris, P; Giordani, MT; Tositti, G; Webster, GJ | 1 |
| Bauditz, J; Roske, AE; Schmidt, HH | 1 |
| Lumb, J | 1 |
| Husa, P | 1 |
| Changchien, CS; Chen, CH; Hung, CH; Lee, CM; Lu, SN; Tung, HD; Wang, JH | 1 |
| Escanhoela, CA; Gonçales, FL; Gonçales, NS; Pavan, MH; Pereira, JS; Silva, Cd | 1 |
| Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J | 1 |
| Jeong, SH; Suh, DJ | 1 |
| Lai, MY | 1 |
| Kekez, AJ | 1 |
| Barcena, R; Blesa, C; Foruny, JR; Garcia-Garzon, S; Garcia-Gonzalez, M; Moreno, A; Moreno-Zamora, A; Oton, E; Ruiz, P | 1 |
| Dieterich, DT; Park, JS; Saraf, N | 1 |
| Anwar, W; Hussain, AB; Saif, M; Sarwar, M; Tariq, WU | 1 |
| Asselah, T; Marcellin, P; Martinot, M; Rautou, PE; Saadoun, D; Valla, D | 1 |
| Dogan, S; Gulec, S; Nuhoglu, A; Urganci, N | 1 |
| Buffet, C | 1 |
| Colonno, R; De Clercq, E; Neyts, J; Ying, C | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G | 1 |
| Amarapurkar, D; Bowden, S; Chow, WC; Chutaputti, A; Dore, G; Gane, E; Guan, R; Hamid, SS; Hardikar, W; Hui, CK; Jafri, W; Jia, JD; Lai, MY; Leung, N; McCaughan, GW; Omata, M; Piratvisuth, T; Sarin, S; Sollano, J; Tateishi, R; Wei, L | 1 |
| Iino, S | 2 |
| Koike, K; Yotsuyanagi, H | 1 |
| Borghi, G; Chemin, I; Chevallier, M; Chevallier, P; Guillaud, O; Menouar, K; Mrani, S; Pradat, P; Trabaud, MA; Trépo, C; Zoulim, F | 1 |
| Dybowska, D; Halota, W | 1 |
| Merigan, TC; Smith, CI | 1 |
| Seeff, LB | 1 |
| White, DO | 1 |
| Banks, SM; Beames, MP; Di Bisceglie, AM; Fong, TL; Fried, MW; Hoofnagle, JH; Park, Y; Swain, MG | 1 |
| Higashi, Y; Ishikawa, T; Kakumu, S; Takayanagi, M; Wakita, T; Yoshioka, K | 1 |
| Dusheiko, GM; Zuckerman, AJ | 1 |
| Chan, CY; Co, RL; Hwang, SJ; Lai, L; Lee, SD; Lu, RH; Tong, MJ | 1 |
| Najm, W | 1 |
| Cattral, MS; Greig, PD; Hemming, AW; Levy, G; Lilly, LB; Philosophe, B; Superina, RA | 1 |
| Galban-García, E; Gra-Oramas, B; Haedo-Castro, D; Jorge-Riaño, JL; Lorenzo-Morejon, I; Ramos-Sanchez, V; Rolo-Gómez, F; Soneiras-Perez, M; Vega-Sanchez, H | 1 |
| Main, J; Thomas, HC; Wright, M | 1 |
| De Clercq, E; Neyts, J; Ying, C | 1 |
| Shermock, KM; Temple, ME; Younossi, ZM | 1 |
| Pol, S | 1 |
| Fontaine, H; Pol, S | 1 |
| Ramrakhiani, S; Sponseller, CA | 1 |
| Lu, Z; Xu, X | 1 |
| Nguyen, MH; Wright, TL | 1 |
| Cooper, DA; Dore, GJ | 1 |
| Brambell, MR; Howard, CR; Jones, DM; Thornton, A; Tsiquaye, KN; Zuckerman, AJ | 1 |
| Zuckerman, AJ | 1 |
| Jain, S; Oxford, JS; Sherlock, S; Thomas, HC | 1 |
| Kew, MC; Seftel, HC | 1 |
| Berquist, KR; Denes, AE; Ebert, JW; Maynard, JE; Murphy, BL | 1 |
| Métreau, JM | 1 |
40 review(s) available for ribavirin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Middle Aged; Recurrence; Ribavirin; Sofosbuvir | 2020 |
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Virus Activation | 2014 |
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Topics: Adenine; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Organophosphonates; Ribavirin; RNA, Viral; Tenofovir; Virus Replication | 2014 |
Perspectives on dual hepatitis B and C infection in Taiwan.
Topics: Antiviral Agents; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Taiwan; Treatment Outcome | 2016 |
[Treatment of systemic vasculitides].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Azathioprine; Churg-Strauss Syndrome; Clinical Trials as Topic; Cryoglobulinemia; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Granulomatosis with Polyangiitis; Hepatitis B; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Plasma Exchange; Polyarteritis Nodosa; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor; Recurrence; Ribavirin; Risk; Severity of Illness Index; Time Factors; Tumor Necrosis Factor-alpha; Vasculitis; Virus Diseases | 2008 |
What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
Topics: Alcoholism; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; HIV Infections; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Metabolic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Current issues in the management of paediatric viral hepatitis.
Topics: Adult; Antiviral Agents; Child; Child, Preschool; Female; Hepatitis A; Hepatitis A Vaccines; Hepatitis A Virus, Human; Hepatitis B; Hepatitis B Vaccines; Hepatitis E; Hepatitis E virus; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure, Acute; Polyethylene Glycols; Pregnancy; Recombinant Proteins; Ribavirin; Vaccination; Viral Hepatitis Vaccines | 2010 |
Treatment and prevention of hepatitis B and C in thalassemia.
Topics: Antiviral Agents; Hemolysis; Hepatitis B; Hepatitis C; Humans; Ribavirin; Thalassemia; Transfusion Reaction | 2009 |
The A, B, Cs of viral hepatitis in the biologic era.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Ribavirin; Rituximab | 2010 |
Thymalfasin in the treatment of hepatitis B and C.
Topics: Adjuvants, Immunologic; Antiviral Agents; Europe; Hepacivirus; Hepatitis B; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Polyethylene Glycols; Polymerase Chain Reaction; Ribavirin; Thymalfasin; Thymosin; Viral Vaccines | 2010 |
Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis C; Humans; Inflammatory Bowel Diseases; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Prevalence; Retrospective Studies; Ribavirin; Tenofovir; Treatment Outcome | 2010 |
Tailor-made therapy for viral hepatitis: recent advances.
Topics: Hepatitis B; Hepatitis C; Humans; Inosine Triphosphatase; Interferon alpha-2; Interferon-alpha; Plasmapheresis; Polyethylene Glycols; Pyrophosphatases; Recombinant Proteins; Ribavirin | 2011 |
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis.
Topics: Antiviral Agents; Asian People; Hepatitis B; Hepatitis C; Humans; Interferons; Ribavirin | 2012 |
[Drug therapy of hepatitis B and C].
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin | 2003 |
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Male; Mutation; Organophosphonates; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors | 2003 |
Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Interferons; Ribavirin | 2004 |
[Current treatment of hepatitis C virus infection].
Topics: Acute Disease; Amantadine; Animals; Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Recurrence; Ribavirin; Transaminases; Treatment Failure; Viral Envelope Proteins; Viral Hepatitis Vaccines | 2005 |
Current status of hepatitis C virus infection in Korea.
Topics: Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Child; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Korea; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Prevalence; Ribavirin; Risk Factors; RNA, Viral; Species Specificity | 2006 |
Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C Antibodies; Hepatitis C, Chronic; Hospitals, University; Humans; Incidence; Interferon-alpha; Liver Neoplasms; Male; Ribavirin; Seroepidemiologic Studies; Taiwan | 2006 |
HBV plus HCV, HCV plus HIV, HBV plus HIV.
Topics: Algorithms; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load | 2006 |
[Acute hepatitis. Biological hepatic anomalies in asymptomatic persons].
Topics: Acute Disease; Adult; Antiviral Agents; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Diagnosis, Differential; France; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Hepatitis D; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Phosphoric Monoester Hydrolases; Prevalence; Ribavirin; Transaminases | 2006 |
[Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?].
Topics: Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Cholestasis, Intrahepatic; Disease-Free Survival; Follow-Up Studies; Hepatitis B; Hepatitis C; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Liver Transplantation; Middle Aged; Patient Compliance; Prognosis; Recurrence; Ribavirin; Risk Factors; Time Factors | 2006 |
[Drugs for hepatitis B and C infection].
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Mutation; Oligopeptides; Organophosphonates; Proline; Ribavirin; Serine Proteinase Inhibitors | 2007 |
[Mechanisms of drug resistance in hepatitis viruses B and C].
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferons; Lamivudine; Mutation; Organophosphonates; Ribavirin; Viral Nonstructural Proteins | 2007 |
[Interferon therapy for hepatitis B and C].
Topics: Antiviral Agents; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2007 |
Therapeutic approaches to chronic hepatitis B.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Azathioprine; Chronic Disease; Guanine; Hepatitis B; Humans; Immunoglobulins; Interferons; Levamisole; Ribavirin; Transfer Factor; Vidarabine; Vidarabine Phosphate | 1982 |
Immunoprophylaxis and treatment of viral hepatitis B.
Topics: Adjuvants, Immunologic; Clinical Trials as Topic; gamma-Globulins; Hepatitis B; Hepatitis B Antibodies; Hepatitis C; Humans; Immunization; Immunization, Passive; Injections; Interferons; Nucleic Acid Synthesis Inhibitors; Ribavirin; Sexually Transmitted Diseases; Vidarabine | 1981 |
Antiviral chemotherapy.
Topics: Acyclovir; Amantadine; Animals; Antiviral Agents; Bromodeoxyuridine; Female; Hepatitis B; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; In Vitro Techniques; Interferons; Male; Neoplasms; Papillomaviridae; Respiratory Tract Infections; Ribavirin; Rimantadine; Tumor Virus Infections; Vidarabine | 1984 |
Treatment of chronic viral hepatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Interferon-alpha; Ribavirin | 1993 |
Viral hepatitis: how to manage type C and D infections.
Topics: Acute Disease; Aged; Antiviral Agents; Chronic Disease; Disease Progression; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin | 1997 |
Drug-resistant viral hepatitis.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Hepacivirus; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Ribavirin | 2000 |
A pharmacoeconomic appraisal of therapies for hepatitis B and C.
Topics: Antiviral Agents; Costs and Cost Analysis; Drug Therapy, Combination; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Ribavirin | 2001 |
[HVB and HVC infections in nephrology].
Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia | 2001 |
[Prevention and treatment of viral hepatitis in renal insufficiency conditions].
Topics: Antiviral Agents; Biopsy; Comorbidity; Contraindications; Cryoglobulinemia; Female; Graft Rejection; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Male; Renal Dialysis; Ribavirin; Severity of Illness Index | 2001 |
Treatment of hepatitis B and C following liver transplantation.
Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Disease Progression; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Prognosis; Ribavirin; Secondary Prevention; Survival Rate | 2002 |
[Hepatic transplantation and HBV reinfection].
Topics: Antiviral Agents; Chemoprevention; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Ribavirin; Secondary Prevention | 2002 |
Therapeutic advances in the management of hepatitis B and hepatitis C.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Ribavirin | 2001 |
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses.
Topics: Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver; Ribavirin; Viremia | 2001 |
Recent advances in viral hepatitis types A and B.
Topics: Animals; Hepatitis A; Hepatitis B; Hepatitis B virus; Hepatovirus; Humans; Interferons; Ribavirin; Serotyping; Vaccination; Vidarabine; Viral Vaccines | 1979 |
[Treatment of chronic active B and non A-non B hepatitis].
Topics: Acyclovir; Adrenal Cortex Hormones; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferons; Ribavirin | 1989 |
11 trial(s) available for ribavirin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Topics: Adult; Antibodies, Viral; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Taiwan; Treatment Outcome; Viral Interference; Viral Load | 2009 |
Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
Topics: Antiviral Agents; Comorbidity; Drug Therapy, Combination; Follow-Up Studies; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Time Factors; Treatment Outcome; Viral Load | 2009 |
Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Recurrence; Retreatment; Ribavirin; RNA, Viral; Viral Load | 2010 |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
Topics: Demography; DNA, Viral; Female; Follow-Up Studies; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Time Factors | 2011 |
Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2005 |
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients.
Topics: Adult; Antiviral Agents; Biopsy; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome | 2005 |
Immunoprophylaxis and treatment of viral hepatitis B.
Topics: Adjuvants, Immunologic; Clinical Trials as Topic; gamma-Globulins; Hepatitis B; Hepatitis B Antibodies; Hepatitis C; Humans; Immunization; Immunization, Passive; Injections; Interferons; Nucleic Acid Synthesis Inhibitors; Ribavirin; Sexually Transmitted Diseases; Vidarabine | 1981 |
Therapy of chronic hepatitis B with a 6-month course of ribavirin.
Topics: Administration, Oral; Adult; Alanine Transaminase; Chronic Disease; Cohort Studies; DNA, Viral; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Nucleosides; Ribavirin; Time Factors; Virus Replication | 1994 |
Pilot study of ribavirin and interferon-beta for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Chronic Disease; DNA-Directed DNA Polymerase; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-beta; Male; Middle Aged; Pilot Projects; Ribavirin | 1993 |
Efficacy of ribavirin in patients with chronic hepatitis B.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biopsy; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Ribavirin | 2000 |
Trial of ribavirin for the treatment of HBsAg positive chronic liver disease.
Topics: Adult; Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Humans; Male; Middle Aged; Ribavirin; Ribonucleosides; Time Factors | 1978 |
61 other study(ies) available for ribavirin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Synthesis and in vitro anti-hepatitis B and C virus activities of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system.
Topics: Antiviral Agents; Benzazepines; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Imidazoles; Nucleosides; Virion | 2005 |
Synthesis and biological evaluation of novel homochiral carbocyclic nucleosides from 1-amino-2-indanols.
Topics: Animals; Antiviral Agents; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cell Line; Chlorocebus aethiops; Diarrhea Viruses, Bovine Viral; Dogs; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Herpes Simplex; Herpesvirus 1, Human; Humans; Indans; Nucleosides; Stereoisomerism; Vero Cells | 2012 |
A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
Topics: Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Liver; Pyrimidine Nucleosides | 2012 |
Sofosbuvir-/Daclatasvir-based therapy for chronic HCV and HCV/hepatitis B virus coinfected patients in Egypt.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Egypt; Genotype; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C, Chronic; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2020 |
Hepatitis B Surface Antigen Decline during Sofosbuvir and Ribavirin Therapy in Hepatitis B Inactive Carriers Who Were Co-infected with Hepatitis C.
Topics: Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; Humans; Retrospective Studies; Ribavirin; Sofosbuvir | 2021 |
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Hepatitis B; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure; Viral Load | 2017 |
Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Immunologic Factors; Prednisolone; Recurrence; Ribavirin; Rituximab; Sofosbuvir; Viral Load | 2017 |
Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.
Topics: Aged; Antiviral Agents; Benzimidazoles; DNA, Viral; Female; Fluorenes; Hepacivirus; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Assessment; Risk Factors; Sofosbuvir; Time Factors; Treatment Outcome; Virus Activation | 2018 |
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Sustained Virologic Response; Taiwan; Viral Load; Young Adult | 2018 |
Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.
Topics: Aged; Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Virus Activation | 2018 |
A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis C; Humans; Interferons; Male; Metabolic Clearance Rate; Middle Aged; Research Design; Retrospective Studies; Ribavirin; ROC Curve | 2018 |
Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report.
Topics: Aged; Antiviral Agents; Asthma; Carbamates; Coinfection; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; Hepatitis E; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tenofovir; Treatment Outcome; Valine; Viral Load | 2020 |
Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?
Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2014 |
Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses.
Topics: Adult; Antiviral Agents; Female; Genetic Variation; Genotype; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin | 2013 |
Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.
Topics: Antiviral Agents; Biomarkers; Coinfection; DNA, Viral; Drug Hypersensitivity Syndrome; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Guanine; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Prednisolone; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load; Virus Activation | 2013 |
[Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Topics: Antiviral Agents; Biomarkers; Contraindications; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Ribavirin | 2015 |
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
Topics: Adult; Antiviral Agents; Biomarkers; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome; Young Adult | 2016 |
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib | 2008 |
Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Treatment of HBV/HCV coinfection: releasing the enemy within.
Topics: Antibodies, Viral; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Interference; Viral Load | 2009 |
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C, Chronic; Hispanic or Latino; Humans; Interferon alpha-2; Interferon-alpha; Mutation; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load; White People | 2009 |
Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2009 |
The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome | 2010 |
Successful treatment of membranoproliferative glomerulonephritis associated with hepatitis B and C virus simultaneous infection patient.
Topics: Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Microscopy, Fluorescence; Middle Aged; Ribavirin; RNA, Viral | 2010 |
Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2010 |
[Treatment of HIV-HCV and HBV-HCV co-infection].
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferons; Ribavirin | 2005 |
Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.
Topics: Adult; Antiviral Agents; Blood; DNA, Viral; Female; France; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prevalence; Reagent Kits, Diagnostic; Recombinant Proteins; Ribavirin | 2010 |
The smoldering epidemic. The number of new cases of hepatitis C is down, but millions are chronically infected and may not know it.
Topics: Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Ribavirin | 2010 |
Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy.
Topics: Adult; Age Distribution; Comorbidity; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2010 |
Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome | 2011 |
Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coinfection; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferons; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Ribavirin; Risk Factors; Young Adult | 2012 |
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome | 2012 |
Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance.
Topics: Adult; Antiviral Agents; Biomarkers; Carrier State; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Portugal; Prospective Studies; Ribavirin; Viral Load | 2013 |
Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
Topics: Aged; Antibodies, Viral; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Superinfection; Treatment Outcome; Viral Load | 2012 |
Trends in viral hepatitis cost-effectiveness studies.
Topics: Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Interferons; Quality-Adjusted Life Years; Ribavirin | 2012 |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome; Viral Core Proteins | 2013 |
Infection fighters. Interferon and ribavirin for hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Humans; Interferons; Interleukin-10; Male; Ribavirin | 2001 |
Characteristics of and current treatment options for hepatitis B and hepatitis C.
Topics: Adult; Antiviral Agents; Drug Combinations; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors; Ribavirin | 2000 |
Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.
Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load; Viremia | 2003 |
Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
[Hemosiderosis in Chronic Hepatitis C: Should Venesection Precede Treatment with Interferon-alpha and Ribavirin?].
Topics: Antiviral Agents; Bloodletting; Combined Modality Therapy; Female; Hemochromatosis Protein; Hemosiderosis; Hepatitis B; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon-alpha; Male; Membrane Proteins; Mutation; Randomized Controlled Trials as Topic; Ribavirin | 2004 |
HIV and hepatitis co-infection: a consensus for treatment?
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Ribavirin | 2005 |
The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients.
Topics: Adult; Antiviral Agents; Biopsy, Needle; Case-Control Studies; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin; Risk Factors | 2004 |
[Treatment of viral hepatitis in children].
Topics: Child; Drug Therapy, Combination; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin | 2005 |
Significance of occult HBV infection in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin; Time Factors; Treatment Outcome | 2006 |
Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin | 2006 |
Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
Topics: Adolescent; Alanine Transaminase; Antiviral Agents; Child; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepacivirus; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis C; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.
Topics: Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Drug Synergism; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mycophenolic Acid; Ribavirin; RNA-Directed DNA Polymerase | 2007 |
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Asia; Australia; Child; Communicable Disease Control; Genotype; Hemophilia A; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Immunoenzyme Techniques; Interferon-alpha; Kidney Failure, Chronic; Liver Transplantation; Molecular Diagnostic Techniques; Reagent Kits, Diagnostic; Ribavirin; RNA, Viral; Thalassemia; Treatment Outcome; Viral Load | 2007 |
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure; Viral Load | 2007 |
[Treatment with natural interferon (alfaferone) in clinical practice--our experience].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome | 2007 |
Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA.
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Monitoring; Hepatitis B; Hepatitis B virus; Humans; Nucleic Acid Hybridization; Polymerase Chain Reaction; Regression Analysis; Ribavirin; Sensitivity and Specificity; Viral Load | 1996 |
The University of Toronto liver transplant program.
Topics: Adult; Alprostadil; Antiviral Agents; Child; Graft Survival; Hepatitis B; Hepatitis C; Hospitals, University; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Neoplasms; Liver Transplantation; Ontario; Patient Selection; Recurrence; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Heterologous | 1996 |
Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.
Topics: Acyclovir; Antiviral Agents; Cell Line; Dideoxynucleosides; Dioxolanes; Drug Synergism; Filaggrin Proteins; Guanine; Guanosine; Hepatitis B; Hepatitis B virus; Humans; Mycophenolic Acid; Purine Nucleosides; Ribavirin; Virus Replication | 2000 |
Very few hepatitis trials recruiting.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Guanine; Hepatitis B; HIV Infections; Humans; Interferon-alpha; Patient Selection; Ribavirin | 1998 |
Opportunistic infections update.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine; Liver; Ribavirin | 1998 |
Hepatitis B outbreak among chimpanzees at the London Zoo.
Topics: Animals; Animals, Zoo; Carrier State; Disease Outbreaks; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis, Animal; Humans; Interferons; London; Pan troglodytes; Ribavirin; Vidarabine | 1978 |
Treatment of chronic hepatitis B virus infection with rebavrin.
Topics: Female; Hepatitis B; Hepatitis B Antigens; Humans; Male; Ribavirin; Ribonucleosides | 1977 |
Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees.
Topics: Animals; Carrier State; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Pan troglodytes; Ribavirin; Ribonucleosides | 1976 |